» Authors » E D Gilby

E D Gilby

Explore the profile of E D Gilby including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 214
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Scully C, Eveson J, Witherow H, Young A, Tan R, Gilby E
Eur J Cancer B Oral Oncol . 1993 Jul; 29B(3):225-9. PMID: 8298427
A 15-year-old male with labial swelling, mouth ulcers and mucosal tags is reported. While the features were clinically consistent with oral Crohn's disease the patient proved to have a fatal...
2.
Betteridge R, Bosanquet A, Gilby E
Eur J Cancer . 1990 Feb; 26(2):107-12. PMID: 2138904
Plasma levels of 2,5-diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone (BZQ, NSC 224070) were measured in nine patients after i.v. administration of the drug during a Phase I trial. Our own isocratic high performance liquid chromatographic...
3.
4.
Bird M, Bosanquet A, Forskitt S, Gilby E
Cancer . 1988 Mar; 61(6):1104-9. PMID: 3342370
A short-term differential staining cytotoxicity (DiSC) assay was used to assess the sensitivity of tumor cells in vitro from patients with chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma to various...
5.
Bird M, Forskitt S, Gilby E, Bosanquet A
Br J Cancer . 1986 Apr; 53(4):539-45. PMID: 3707845
The Differential Staining Cytotoxicity (DiSC) assay has been used to study the effects of sample source and cell concentration on the in vitro chemosensitivity of haematological malignancies. The chemosensitivity of...
6.
Bird M, Bosanquet A, Forskitt S, Gilby E
Leuk Res . 1986 Jan; 10(4):445-9. PMID: 2421109
A semi-micro differential staining cytotoxicity (micro-DiSC) assay has been developed to determine the in-vitro chemosensitivity of haematological cancers. The method comprised isolation of leukocytes from blood or bone marrow, drug...
7.
Bird M, Bosanquet A, Gilby E
Hematol Oncol . 1985 Jan; 3(1):1-10. PMID: 2580768
A four-day tumour chemosensitivity assay of potential use in predicting tumour response to cytotoxic drugs has been developed for haematological cancers. The method comprised isolation of white cells from peripheral...
8.
Bosanquet A, Gilby E
Cancer Chemother Pharmacol . 1984 Jan; 12(3):183-6. PMID: 6705135
Melphalan absorption was studied over three consecutive days in five patients with multiple myeloma. On 1 day melphalan (approximately 7 mg/m2 = 10-12 mg) was administered IV, on 1 day...
9.
Bosanquet A, Bird M, Price W, Gilby E
Br J Cancer . 1983 Jun; 47(6):781-9. PMID: 6190492
A 4-day tumour sensitivity assay of potential use in predicting tumour response to cytotoxic drugs has been investigated in patients with chronic lymphocytic leukaemia. The method comprised isolation of white...
10.
Bondy P, Gilby E
Cancer . 1982 Nov; 50(10):2147-53. PMID: 6290025
The endocrine status of 106 patients with undifferentiated small cell carcinoma of the lung was evaluated before treatment was begun. Almost one half of the patients had evidence of abnormal...